| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.49 | 0.08 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |